Alysena 21 and 28

ALYSENA 21 AND ALYSENA 28 BIRTH CONTROL CLASS ACTION

Rice Harbut Elliott LLP has commenced proceedings in a class action lawsuit, representing Canadian women who were prescribed “Alysena 21” or “Alysena 28” birth control pills, in which Health Canada had issued public advisories in February 2018 and March 2018.

Overview
Full Details

Overview

Current Status: Settled.

A settlement agreement has been reached, subject to approval of the Court. The settlement approval hearing is scheduled for May 16, see here for the settlement agreement and notices in French and English. For more information, please visit the settlement website www.alysenaclassaction.ca.

The affected “Alysena 21” or “Alysena 28” pills reportedly involved chipped, broken, or smaller-than-normal pills, leading to unintended pregnancies. At present, the recall involves pills from all lots of:

Alysena 21 (DIN 02387875)
Alysena 28 (DIN 02387883)

Our firm is seeking compensation for Canadian women who received “Alysena 21” or “Alysena 28” birth control pills that may have been involved in the manufacturing defect. Damages will be sought both for women who experienced unintended pregnancies and other women who received pills that were recalled. The latter group may be entitled to compensation pursuant to B.C. consumer protection legislation.

If you received “Alysena 21” or “Alysena 28” birth control pills, you may be affected by this class action lawsuit. Please fill out the form below to get in touch with us. Joining our contact list creates no financial obligation and we will keep all the information that you provide to us confidential.

Full Details

The full details of the Health Canada recall can be found here.

Alysena 21 and 28 Form

Note: You are not obliged to fill in this form to participate in this class action. If you choose to do so, you are not retaining RHE LLP to act on your behalf. Providing the information requested does not make you a client of RHE LLP. All information submitted will be treated as confidential and will only be released as required by law or as you may consent.

I provide my consent and agree herein to receive communications from RHE LLP, which may include announcements regarding class actions, practice updates, newsletters, publications, event invitations or other information that may be of interest. I understand that consent to receive these electronic communications may be withdrawn at any time by emailing reception@rhelaw.com.

Class Action Form

Contact Information

Name *

First

Last

Email *

Phone

FAX

Address (unit no., building/house number, street name)

City/ Town

Province

Postal Code

Subject

DATE OF BIRTH *

PERSONAL HEALTH NUMBER *

DATE OF PRESCRIPTION *

DATE THAT YOU SOUGHT MEDICAL TREATMENT FOR YOUR SYMPTOMS

ARE YOU AWARE OF THE CANADIAN ALYSENA 21/28 RECALL? *

WERE YOU TAKING THE DRUGS PRIOR TO THE HEALTH CANADA PUBLIC ADVISORIES IN FEBRUARY 2018 AND MARCH 2018? *

DID YOU BECOME PREGNANT WHILE TAKING ALYSENA? *

WHEN DID YOU BECOME AWARE OF THE RECALL?

PLEASE LIST ALL THE SYMPTOMS YOU EXPERIENCED. (PREGNANCY, OTHER)

OTHER COMMENTS

Consent *

I provide my consent and agree herein to receive communications from RHE LLP, which may include announcements regarding class actions, practice updates, newsletters, publications, event invitations or other information that may be of interest. I understand that I can unsubscribe to these emails at any time. I understand that some of the personal information that I provide may be stored or processed outside of British Columbia and/or Canada, on a US server, and will be kept confidential, subject to the potential that a foreign state may seek to access the data for “lawful access” purposes. If you have any questions about RHE’s policies and practices regarding service providers outside Canada, or about the collection, use, disclosure or storage of personal information by the service providers outside Canada, please contact reception@rhelaw.com.

Custom Captcha *